The 2nd Subcommittee on Rare Cancers

Agenda

1. Expectation for Drug Development for Rare Cancers –from the Clinical Site- (Dr. Akira Kawai, a Member of the Subcommittee)
2. Clinical Development of Rare Cancers by Genome Analysis (Dr. Tatsuhiro Shibata, a Member of the Subcommittee)
3. Points to Consider and Future Plan
4. Others

List of Handouts

• Document 1　Rationale to Discuss Rare Cancers
• Document 2　Points to Consider (Chart)
• Document 3　The 1st Subcommittee Minutes Summary
• Document 4　The 1st Subcommittee Minutes Summary (Chart)  
• Document 5　Lecture Materials (Dr. Akira Kawai, a Member)  
• Document 6　Lecture Materials (Dr. Tatsuhiro Shibata, a Member)